We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current 1BAX market cap is 16.39B. The company's latest EPS is USD -1.2685 and P/E is -27.27.
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 11.69B | 12.79B | 15.11B | 14.84B | 15.16B |
| Operating Income | 1.5B | 1.71B | -1.93B | 397M | -98M |
| Net Income | 980M | 1.28B | -2.43B | 2.66B | -649M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 20.02B | 33.52B | 28.29B | 28.28B | 25.78B |
| Total Liabilities | 11.29B | 24.4B | 22.39B | 19.81B | 18.76B |
| Total Equity | 8.73B | 9.12B | 5.9B | 8.47B | 7.02B |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 1.87B | 2.22B | 1.21B | 1.73B | 1.02B |
| Investing | -1.18B | -11.2B | -931M | 3.21B | -626M |
| Financing | -345M | 8.25B | -1.44B | -3.49B | -1.08B |
| Market Cap | 16.39B |
| Price to Earnings Ratio | -27.27 |
| Price to Sales Ratio | 1.17 |
| Price to Cash Ratio | 10.03 |
| Price to Book Ratio | 2.52 |
| Dividend Yield | 2.32% |
| Shares Outstanding | 511.62M |
| Average Volume (1 week) | 809 |
| Average Volume (1 Month) | 385 |
| 52 Week Change | 0.75% |
| 52 Week High | 36.00 |
| 52 Week Low | 30.12 |
| Spread (Intraday) | 0.33 (1.01%) |
| Company Name | Baxter International Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.baxter.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
